CAS: 859209-74-8 - GS-9219
Formula:C21H35N8O6P
InChI:InChI=1S/C21H35N8O6P/c1-5-34-19(30)13(3)27-36(32,28-14(4)20(31)35-6-2)12-33-10-9-29-11-23-16-17(24-15-7-8-15)25-21(22)26-18(16)29/h11,13-15H,5-10,12H2,1-4H3,(H2,27,28,32)(H3,22,24,25,26)/t13-,14-/m0/s1
InChI key:InChIKey=ANSPEDQTHURSFQ-KBPBESRZSA-N
SMILES:O=C(OCC)C(NP(=O)(NC(C(=O)OCC)C)COCCN1C=NC=2C(=NC(=NC21)N)NC3CC3)C
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Rabacfosadine REF: TM-T16716CAS: 859209-74-8 | 98.75% - 99.43% | 153.00 €~1,573.00 € | Thu 17 Oct 24 |
 | Rabacfosadine REF: 3D-JJB20974CAS: 859209-74-8 | Min. 95% | To inquire | Mon 25 Nov 24 |
Rabacfosadine
CAS:859209-74-8
Rabacfosadine (GS-9219) is a novel prodrug of PMEG, an acyclic nucleotide phosphonate, with antitumor activity …
Formula:
C21H35N8O6P
Purity:
98.75% - 99.43%
Color and Shape:
Solid
Molecular weight:
526.53
Ref: TM-T16716
| 1mg | 153.00 € | ||
| 5mg | 364.00 € | ||
| 10mg | 542.00 € | ||
| 25mg | 869.00 € | ||
| 50mg | 1,179.00 € | ||
| 100mg | 1,573.00 € |
Estimated delivery in United States, on Thursday 17 Oct 2024
Rabacfosadine
CAS:859209-74-8
Rabacfosadine is a novel antiviral drug that has been shown to be effective in the …
Formula:
C21H35N8O6P
Purity:
Min. 95%
Molecular weight:
526.5 g/mol
Ref: 3D-JJB20974
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 25 Nov 2024
